Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Recombinant Human Somatropin
Revenue, means the sales value of Recombinant Human Somatropin
This report studies sales (consumption) of Recombinant Human Somatropin in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Recombinant Human Somatropin in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Injection
Freeze-dried powder
Split by application, this report focuses on sales, market share and growth rate of Recombinant Human Somatropin in each application, can be divided into
Hospital Use
Clinic Use
Others
Europe Recombinant Human Somatropin Market Report 2017
1 Recombinant Human Somatropin Overview
1.1 Product Overview and Scope of Recombinant Human Somatropin
1.2 Classification of Recombinant Human Somatropin
1.2.1 Injection
1.2.2 Freeze-dried powder
1.3 Application of Recombinant Human Somatropin
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Others
1.4 Recombinant Human Somatropin Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Recombinant Human Somatropin (2012-2022)
1.5.1 Europe Recombinant Human Somatropin Sales and Growth Rate (2012-2022)
1.5.2 Europe Recombinant Human Somatropin Revenue and Growth Rate (2012-2022)
2 Europe Recombinant Human Somatropin by Manufacturers, Type and Application
2.1 Europe Recombinant Human Somatropin Market Competition by Manufacturers
2.1.1 Europe Recombinant Human Somatropin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Recombinant Human Somatropin Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Recombinant Human Somatropin (Volume and Value) by Type
2.2.1 Europe Recombinant Human Somatropin Sales and Market Share by Type (2012-2017)
2.2.2 Europe Recombinant Human Somatropin Revenue and Market Share by Type (2012-2017)
2.3 Europe Recombinant Human Somatropin (Volume and Value) by Countries
2.3.1 Europe Recombinant Human Somatropin Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Recombinant Human Somatropin Revenue and Market Share by Countries (2012-2017)
2.4 Europe Recombinant Human Somatropin (Volume) by Application
3 Germany Recombinant Human Somatropin (Volume, Value and Sales Price)
3.1 Germany Recombinant Human Somatropin Sales and Value (2012-2017)
3.1.1 Germany Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
3.1.2 Germany Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
3.1.3 Germany Recombinant Human Somatropin Sales Price Trend (2012-2017)
3.2 Germany Recombinant Human Somatropin Sales and Market Share by Manufacturers
3.3 Germany Recombinant Human Somatropin Sales and Market Share by Type
3.4 Germany Recombinant Human Somatropin Sales and Market Share by Application
4 France Recombinant Human Somatropin (Volume, Value and Sales Price)
4.1 France Recombinant Human Somatropin Sales and Value (2012-2017)
4.1.1 France Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
4.1.2 France Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
4.1.4 France Recombinant Human Somatropin Sales Price Trend (2012-2017)
4.2 France Recombinant Human Somatropin Sales and Market Share by Manufacturers
4.3 France Recombinant Human Somatropin Sales and Market Share by Type
4.4 France Recombinant Human Somatropin Sales and Market Share by Application
5 UK Recombinant Human Somatropin (Volume, Value and Sales Price)
5.1 UK Recombinant Human Somatropin Sales and Value (2012-2017)
5.1.1 UK Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
5.1.2 UK Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
5.1.5 UK Recombinant Human Somatropin Sales Price Trend (2012-2017)
5.2 UK Recombinant Human Somatropin Sales and Market Share by Manufacturers
5.3 UK Recombinant Human Somatropin Sales and Market Share by Type
5.4 UK Recombinant Human Somatropin Sales and Market Share by Application
6 Russia Recombinant Human Somatropin (Volume, Value and Sales Price)
6.1 Russia Recombinant Human Somatropin Sales and Value (2012-2017)
6.1.1 Russia Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
6.1.2 Russia Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
6.1.6 Russia Recombinant Human Somatropin Sales Price Trend (2012-2017)
6.2 Russia Recombinant Human Somatropin Sales and Market Share by Manufacturers
6.3 Russia Recombinant Human Somatropin Sales and Market Share by Type
6.4 Russia Recombinant Human Somatropin Sales and Market Share by Application
7 Italy Recombinant Human Somatropin (Volume, Value and Sales Price)
7.1 Italy Recombinant Human Somatropin Sales and Value (2012-2017)
7.1.1 Italy Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
7.1.2 Italy Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
7.1.7 Italy Recombinant Human Somatropin Sales Price Trend (2012-2017)
7.2 Italy Recombinant Human Somatropin Sales and Market Share by Manufacturers
7.3 Italy Recombinant Human Somatropin Sales and Market Share by Type
7.4 Italy Recombinant Human Somatropin Sales and Market Share by Application
8 Spain Recombinant Human Somatropin (Volume, Value and Sales Price)
8.1 Spain Recombinant Human Somatropin Sales and Value (2012-2017)
8.1.1 Spain Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
8.1.2 Spain Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
8.1.8 Spain Recombinant Human Somatropin Sales Price Trend (2012-2017)
8.2 Spain Recombinant Human Somatropin Sales and Market Share by Manufacturers
8.3 Spain Recombinant Human Somatropin Sales and Market Share by Type
8.4 Spain Recombinant Human Somatropin Sales and Market Share by Application
9 Benelux Recombinant Human Somatropin (Volume, Value and Sales Price)
9.1 Benelux Recombinant Human Somatropin Sales and Value (2012-2017)
9.1.1 Benelux Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
9.1.2 Benelux Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Recombinant Human Somatropin Sales Price Trend (2012-2017)
9.2 Benelux Recombinant Human Somatropin Sales and Market Share by Manufacturers
9.3 Benelux Recombinant Human Somatropin Sales and Market Share by Type
9.4 Benelux Recombinant Human Somatropin Sales and Market Share by Application
10 Europe Recombinant Human Somatropin Manufacturers Analysis
11 Recombinant Human Somatropin Manufacturing Cost Analysis
11.1 Recombinant Human Somatropin Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Recombinant Human Somatropin
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Recombinant Human Somatropin Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Recombinant Human Somatropin Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Recombinant Human Somatropin Market Forecast (2017-2022)
14.1 Germany Recombinant Human Somatropin Sales Forecast (2017-2022)
14.2 France Recombinant Human Somatropin Sales Forecast (2017-2022)
14.3 UK Recombinant Human Somatropin Sales Forecast (2017-2022)
14.4 Russia Recombinant Human Somatropin Sales Forecast (2017-2022)
14.5 Italy Recombinant Human Somatropin Sales Forecast (2017-2022)
14.6 Spain Recombinant Human Somatropin Sales Forecast (2017-2022)
14.7 Benelux Recombinant Human Somatropin Sales Forecast (2017-2022)
14.8 Europe Recombinant Human Somatropin Sales Forecast by Type (2017-2022)
14.9 Europe Recombinant Human Somatropin Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Recombinant Human Somatropin
Table Classification of Recombinant Human Somatropin
Figure Europe Sales Market Share of Recombinant Human Somatropin by Type in 2015
Figure Injection Picture
Figure Freeze-dried powder Picture
Table Application of Recombinant Human Somatropin
Figure Europe Sales Market Share of Recombinant Human Somatropin by Application in 2015
Figure Hospital Use Examples
Figure Clinic Use Examples
Figure Others Examples
Figure Germany Recombinant Human Somatropin Revenue and Growth Rate (2012-2022)
Figure France Recombinant Human Somatropin Revenue and Growth Rate (2012-2022)
Figure UK Recombinant Human Somatropin Revenue and Growth Rate (2012-2022)
Figure Russia Recombinant Human Somatropin Revenue and Growth Rate (2012-2022)
Figure Italy Recombinant Human Somatropin Revenue and Growth Rate (2012-2022)
Figure Spain Recombinant Human Somatropin Revenue and Growth Rate (2012-2022)
Figure Benelux Recombinant Human Somatropin Revenue and Growth Rate (2012-2022)
Figure Europe Recombinant Human Somatropin Sales and Growth Rate (2012-2022)
Figure Europe Recombinant Human Somatropin Revenue and Growth Rate (2012-2022)
Table Europe Recombinant Human Somatropin Sales of Key Manufacturers (2015 and 2016)
Table Europe Recombinant Human Somatropin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Human Somatropin Sales Share by Manufacturers
Figure 2016 Recombinant Human Somatropin Sales Share by Manufacturers
Table Europe Recombinant Human Somatropin Revenue by Manufacturers (2015 and 2016)
Table Europe Recombinant Human Somatropin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Recombinant Human Somatropin Revenue Share by Manufacturers
Table 2016 Europe Recombinant Human Somatropin Revenue Share by Manufacturers
Table Europe Recombinant Human Somatropin Sales and Market Share by Type (2012-2017)
Table Europe Recombinant Human Somatropin Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Human Somatropin by Type (2012-2017)
Figure Europe Recombinant Human Somatropin Sales Growth Rate by Type (2012-2017)
Table Europe Recombinant Human Somatropin Revenue and Market Share by Type (2012-2017)
Table Europe Recombinant Human Somatropin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Human Somatropin by Type (2012-2017)
Figure Europe Recombinant Human Somatropin Revenue Growth Rate by Type (2012-2017)
Table Europe Recombinant Human Somatropin Sales and Market Share by Countries (2012-2017)
Table Europe Recombinant Human Somatropin Sales Share by Countries (2012-2017)
Figure Sales Market Share of Recombinant Human Somatropin by Countries (2012-2017)
Table Europe Recombinant Human Somatropin Revenue and Market Share by Countries (2012-2017)
Table Europe Recombinant Human Somatropin Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Recombinant Human Somatropin by Countries (2012-2017)
Table Europe Recombinant Human Somatropin Sales and Market Share by Application (2012-2017)
Table Europe Recombinant Human Somatropin Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Human Somatropin by Application (2012-2017)
Figure Germany Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
Figure Germany Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
Figure Germany Recombinant Human Somatropin Sales Price Trend (2012-2017)
Table Germany Recombinant Human Somatropin Sales by Manufacturers (2015 and 2016)
Table Germany Recombinant Human Somatropin Market Share by Manufacturers (2015 and 2016)
Table Germany Recombinant Human Somatropin Sales by Type (2015 and 2016)
Table Germany Recombinant Human Somatropin Market Share by Type (2015 and 2016)
Table Germany Recombinant Human Somatropin Sales by Application (2015 and 2016)
Table Germany Recombinant Human Somatropin Market Share by Application (2015 and 2016)
Figure France Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
Figure France Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
Figure France Recombinant Human Somatropin Sales Price Trend (2012-2017)
Table France Recombinant Human Somatropin Sales by Manufacturers (2015 and 2016)
Table France Recombinant Human Somatropin Market Share by Manufacturers (2015 and 2016)
Table France Recombinant Human Somatropin Sales by Type (2015 and 2016)
Table France Recombinant Human Somatropin Market Share by Type (2015 and 2016)
Table France Recombinant Human Somatropin Sales by Application (2015 and 2016)
Table France Recombinant Human Somatropin Market Share by Application (2015 and 2016)
Figure UK Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
Figure UK Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
Figure UK Recombinant Human Somatropin Sales Price Trend (2012-2017)
Table UK Recombinant Human Somatropin Sales by Manufacturers (2015 and 2016)
Table UK Recombinant Human Somatropin Market Share by Manufacturers (2015 and 2016)
Table UK Recombinant Human Somatropin Sales by Type (2015 and 2016)
Table UK Recombinant Human Somatropin Market Share by Type (2015 and 2016)
Table UK Recombinant Human Somatropin Sales by Application (2015 and 2016)
Table UK Recombinant Human Somatropin Market Share by Application (2015 and 2016)
Figure Russia Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
Figure Russia Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
Figure Russia Recombinant Human Somatropin Sales Price Trend (2012-2017)
Table Russia Recombinant Human Somatropin Sales by Manufacturers (2015 and 2016)
Table Russia Recombinant Human Somatropin Market Share by Manufacturers (2015 and 2016)
Table Russia Recombinant Human Somatropin Sales by Type (2015 and 2016)
Table Russia Recombinant Human Somatropin Market Share by Type (2015 and 2016)
Table Russia Recombinant Human Somatropin Sales by Application (2015 and 2016)
Table Russia Recombinant Human Somatropin Market Share by Application (2015 and 2016)
Figure Italy Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
Figure Italy Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
Figure Italy Recombinant Human Somatropin Sales Price Trend (2012-2017)
Table Italy Recombinant Human Somatropin Sales by Manufacturers (2015 and 2016)
Table Italy Recombinant Human Somatropin Market Share by Manufacturers (2015 and 2016)
Table Italy Recombinant Human Somatropin Sales by Type (2015 and 2016)
Table Italy Recombinant Human Somatropin Market Share by Type (2015 and 2016)
Table Italy Recombinant Human Somatropin Sales by Application (2015 and 2016)
Table Italy Recombinant Human Somatropin Market Share by Application (2015 and 2016)
Figure Spain Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
Figure Spain Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
Figure Spain Recombinant Human Somatropin Sales Price Trend (2012-2017)
Table Spain Recombinant Human Somatropin Sales by Manufacturers (2015 and 2016)
Table Spain Recombinant Human Somatropin Market Share by Manufacturers (2015 and 2016)
Table Spain Recombinant Human Somatropin Sales by Type (2015 and 2016)
Table Spain Recombinant Human Somatropin Market Share by Type (2015 and 2016)
Table Spain Recombinant Human Somatropin Sales by Application (2015 and 2016)
Table Spain Recombinant Human Somatropin Market Share by Application (2015 and 2016)
Figure Benelux Recombinant Human Somatropin Sales and Growth Rate (2012-2017)
Figure Benelux Recombinant Human Somatropin Revenue and Growth Rate (2012-2017)
Figure Benelux Recombinant Human Somatropin Sales Price Trend (2012-2017)
Table Benelux Recombinant Human Somatropin Sales by Manufacturers (2015 and 2016)
Table Benelux Recombinant Human Somatropin Market Share by Manufacturers (2015 and 2016)
Table Benelux Recombinant Human Somatropin Sales by Type (2015 and 2016)
Table Benelux Recombinant Human Somatropin Market Share by Type (2015 and 2016)
Table Benelux Recombinant Human Somatropin Sales by Application (2015 and 2016)
Table Benelux Recombinant Human Somatropin Market Share by Application (2015 and 2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Somatropin
Figure Manufacturing Process Analysis of Recombinant Human Somatropin
Figure Recombinant Human Somatropin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Somatropin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Somatropin
Table Distributors/Traders List
Figure Germany Recombinant Human Somatropin Sales and Growth Rate Forecast (2017-2022)
Figure Germany Recombinant Human Somatropin Revenue and Growth Rate Forecast (2017-2022)
Figure France Recombinant Human Somatropin Sales and Growth Rate Forecast (2017-2022)
Figure France Recombinant Human Somatropin Revenue and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Human Somatropin Sales and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Human Somatropin Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Human Somatropin Sales and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Human Somatropin Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Human Somatropin Sales and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Human Somatropin Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Human Somatropin Sales and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Human Somatropin Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Human Somatropin Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Human Somatropin Revenue and Growth Rate Forecast (2017-2022)
Table Europe Recombinant Human Somatropin Sales Forecast by Type (2017-2022)
Table Europe Recombinant Human Somatropin Sales Forecast by Application (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...